Senti Biosciences Holdings (SNTI) Free Cash Flow (2021 - 2025)

Senti Biosciences Holdings' Free Cash Flow history runs 5 years deep, the most recent figure standing at -$6.9 million for Q4 2025.

• In Q4 2025, Free Cash Flow rose 49.13% year-over-year to -$6.9 million; the TTM figure through Dec 2025 stood at -$43.6 million (down 5.35% YoY), while the FY2025 annual figure was -$43.6 million, down 5.35% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$6.9 million, up from -$9.4 million in the prior quarter.
• The five-year high for Free Cash Flow was $1.1 million in Q3 2022, with the low at -$43.0 million in Q4 2022.
• The 5-year median for Free Cash Flow is -$9.4 million (2025), against an average of -$11.6 million.
• Peak annual rise in Free Cash Flow reached 152.52% in 2022, while the deepest fall reached 1549.24% in 2022.
• Senti Biosciences Holdings' Free Cash Flow stood at -$4.0 million in 2021, then tumbled by 969.29% to -$43.0 million in 2022, then surged by 83.61% to -$7.0 million in 2023, then slumped by 91.73% to -$13.5 million in 2024, then soared by 49.13% to -$6.9 million in 2025.
• Business Quant data shows SNTI's Free Cash Flow at -$6.9 million in Q4 2025, -$9.4 million in Q3 2025, and -$13.1 million in Q2 2025.